Start with initial screening – build towards ongoing AML compliance​

Do you know who you are doing business with?

Understanding your counterparties is key to managing risk and staying compliant. Driven by increasing regulatory expectations, including AMLR and EBA guidelines.​

Challenges
  • Limited visibility of counterparties
  • Increasing sanctions and regulatory pressure
  • Risk of unknowingly engaging with high-risk entities
  • Manual processes and inconsistent screening
Potential impact​
  • Transactions with sanctioned or restricted parties​
  • Financial penalties and fines​
  • Reputational damage​
  • Regulatory scrutiny

Structured screening is essential to identify and manage counterparty risk.


CM1 Kickstart – Initial Screening​

  • Initial screening of counterparties​
  • Quick and easy data onboarding​
  • Identify potential risk exposures​
  • Access to results in CM1​
  • Basic review support​
  • Guide and introduction to CM1 Screening​

A first step to gain control over your counterparties​.

Price SEK 15 000 ex VAT

CM1 Ongoing Compliance​

  • Continuous screening (daily updates)​
  • Ongoing monitoring of counterparties​
  • Alert and case handling​
  • Risk-based follow-up​
  • Full access to CM1 platform

​Ensures ongoing AML compliance over time​.

Contact us for pricing!


Increasing Regulatory Pressure on Screening​

Regulations and sanctions frameworks are continuously evolving. Aligned with AMLR and EBA expectations on ongoing monitoring​.


​What is happening​

  • Expanding sanctions frameworks
  • Increased focus on circumvention
  • More entities and individuals listed
  • Higher expectations from regulators

What it means​

  • Screening must be ongoing
  • Risk must be continuously assessed
  • One-time checks are not sufficient.
  • Continuous monitoring is required

Ongoing screening is essential to meet regulatory expectations.​


Contact me

This field is for validation purposes and should be left unchanged.